Shilong Deng

Exploration of the Tumor Immune Landscape and Identification of Two Novel Immunotherapy-Related Genes for Epstein-Barr virus-associated Gastric Carcinoma via Integrated Bioinformatics Analysis

Xiang-Xu Wang, Hong-mei Zhang, Shilong Deng, 2022, Frontiers in Surgery.

Construction of m6A-based prognosis signature and prediction for immune and anti-angiogenic response

Ya-jie Lu, L. Ai, Qing-Qing Liu, 2022, Frontiers in Molecular Biosciences.

A novel cuproptosis-related prognostic signature and potential value in HCC immunotherapy

W. Pan, L. Ai, Qing-Qing Liu, 2022, Frontiers in Molecular Biosciences.

LINC00324 affects non-small cell lung cancer cell proliferation and invasion through regulation of the miR-139-5p/IGF1R axis

Tengfei Huang, Shilong Deng, Duohuang Lian, 2020, Molecular and Cellular Biochemistry.

Cuproptosis-Mediated Patterns Characterized by Distinct Tumor Microenvironment and Predicted the Immunotherapy Response for Gastric Cancer

G. Zheng, Jianyong Zheng, Qing-Qing Liu, 2023, ACS omega.

Integrative analysis of lysine acetylation-related genes and identification of a novel prognostic model for oral squamous cell carcinoma

Xuechen Wu, Shilong Deng, Lin Dai, 2023, Frontiers in molecular biosciences.

Long non-coding RNA DDX11-AS1 promotes non-small cell lung cancer development via regulating PI3K/AKT signaling.

Shengsheng Yang, Shilong Deng, Xuegang Feng, 2020, Clinical and experimental pharmacology & physiology.